Close
Back to MGNX Stock Lookup

Macrogenics (MGNX) – Hot FDA News

Apr 3, 2024 04:30 PM Macrogenics (MGNX) Provides Phase 2 TAMARACK Study Early Interim Safety Data and Plans for Future Disclosures
Sep 7, 2021 04:34 PM Macrogenics (MGNX) OS Results from SOPHIA Study of MARGENZA in Patients with HER2-Positive Metastatic Breast Cancer Did Not Demonstrate Statistically Significant Advantage
Dec 16, 2020 05:23 PM
May 13, 2020 05:12 PM
May 15, 2019 05:10 PM
Feb 6, 2019 06:00 AM
Dec 7, 2018 04:01 PM
Sep 11, 2017 06:00 AM

Back to MGNX Stock Lookup